NARSAD
Welcome, guest
[login or register]
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Rita J. Valentino, Ph.D. (Distinguished Investigator 2002) of Children's Hospital of Philadelphia, points out that recent studies have revealed a role for neuropeptides, specifically corticotropin-releasing factor (CRF) and Substance P (SP), in affective disorders.  This has sparked the development of novel therapeutic agents that target these peptides.  The efficacy of drugs that target the neuropeptides, as well as drugs that target serotonin (5-HT) suggest that loci in circuits where these neuromediators converge may be the focus of the pathophysiology.  Elucidating interactions between these neuromediators at these loci of convergence is critical to understanding the pathophysiology of affective disorders and providing a rationale for the development of therapeutic agents.  Dr. Valentino recently identified a point of convergence within the dorsal raphe nucleus (DR) where 5-HT, CRF and SP may interact.  The DR, a major source of 5-HT cell bodies that project to forebrain regions involved in cognition and emotion, can be divided into subnuclei that have distinct afferent and efferent connections.  She will use a novel approach of intracellular labeling following juxtacellular neuronal recording in vivo.  This powerful approach has been used to characterize cardiovascular responsive neurons in the medulla and she recently had success using this technique to intracellularly label Barrington's nucleus neurons following recording responses to visceral stimulation.  Dr. Valentino hopes to further develop the approach of in vivo intracellular labeling from biogenic amine neurons.  This is a powerful technique because it allows her to characterize the morphology, neurochemical identity, sensitivity to various stimuli and neural connectivity within a system, which cannot be done in vitro.  A long range plan is to use this approach to manipulate gene expression of selected neurons in this region and determine the impact of this on behavior.

Program Area: MOOD DISORDERS\Mood Disorders (General)

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Independent Investigator application deadline: March 5, 2008

2008 Young Investigator, 2008 Distinguished Investigator and 2008 Staglin Grantees Announced: March, 2008

2008 Distinguished Investigator Earliest Start Date: May 1, 2008

2009 Distinguished Investigator Award application deadline: May 15, 2008

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award application deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Award Earliest Start Date: September 15, 2008

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009





NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us